by Mrudula Kulkarni

2 minutes

Scott Thomson Is Appointed As The New CEO Of Actylis

Actylis appoints Scott Thomson as CEO to drive growth in life sciences and specialty chemicals.

Scott Thomson Is Appointed As The New CEO Of Actylis

Actylis, an international manufacturer and sourcing specialist for essential materials and performance ingredients in the life sciences and specialty chemicals sectors, has named Scott Thomson as its new Chief Executive Officer.

Scott Thomson brings thirty years of experience in the pharmaceutical and chemical industries to his new role. He previously served as CEO of SPI Pharma, a global supplier of pharmaceutical ingredients, systems, and services, where he played a key role in enhancing the company's strategic development and execution. Before joining SPI Pharma, Thomson held senior executive positions at BASF, overseeing multiple global life science and specialty ingredients businesses.

 RakeshSachdev, Chairman of Actylis, remarked, “Scott has an impressive tenure of driving long-term growth, and we look forward to welcoming Scott as we bring our client-centric, flexible customer service model and extensive product offerings to an increasing number of geographies, customers and applications.”

 Thomson commented, “I feel privileged to lead the Actylis team at this exciting juncture, and I look forward to partnering with our customers, Actylis’ management and employees, and New Mountain to grow and further develop Actylis’ offerings. There is a significant opportunity to accelerate the company’s growth and I look forward to building upon the company’s achievements to date both organically and inorganically.”



Author Profile

Mrudula Kulkarni

Researcher Assistant

Comment your thoughts

Author Profile

Mrudula Kulkarni

Researcher Assistant

Ad
Advertisement

You may also like

Article
Teva Pharmaceutical Welcomes Matthew Shields as Executive Vice President of Global Operations

Mrudula Kulkarni